MPTP公司
黑质
致密部
神经科学
多巴胺能
帕金森病
化学
神经毒素
药理学
心理学
多巴胺
医学
内科学
疾病
生物化学
作者
Hongwei Cai,Pei Zhang,Tongxia Li,Ming Li,Lijun Zhang,Chi Cui,Jie Lei,Jian Yang,Kun Ren,Jie Ming,Bo Tian
摘要
Abstract Aims The aim was to investigate the effect of mood disorders on parkinsonian toxin 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced motor disability, substantia nigra pars compacta (SNc) dopaminergic (DA) neurons loss. Also, the neural circuit mechanism was elucidated. Methods The depression‐like (physical stress, PS) and anxiety‐like (emotional stress, ES) mouse models were established by the three‐chamber social defeat stress (SDS). The features of Parkinson's disease were reproduced by MPTP injection. Viral‐based whole‐brain mapping was utilized to resolve the stress‐induced global changes in direct inputs onto SNc DA neurons. Calcium imaging and chemogenetic techniques were applied to verify the function of the related neural pathway. Results We found that PS mice, but not ES mice, showed worse movement performance and more SNc DA neuronal loss than control mice after MPTP administration. The projection from the central amygdala (CeA) to the SNc DA was significantly increased in PS mice. The activity of SNc‐projected CeA neurons was enhanced in PS mice. Activating or inhibiting the CeA‐SNc DA pathway could mimic or block PS‐induced vulnerability to MPTP. Conclusions These results indicated that projections from CeA to SNc DA neurons contribute to SDS‐induced vulnerability to MPTP in mice.
科研通智能强力驱动
Strongly Powered by AbleSci AI